# OnCo record cimab (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cimab/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cimab" ;
  schema:name "CIMAB"@en ;
  schema:alternateName "CIMAB S.A."@en, "Center of Molecular Immunology"@en, "Centro de Inmunología Molecular"@en, "CIM"@en ;
  schema:description "CIMAB is the commercial arm of Havana's Center of Molecular Immunology, the Cuban institute that created the EGFR antibody nimotuzumab and the lung cancer vaccine CIMAvax-EGF."@en ;
  schema:url <https://onco.cc/companies/cimab/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:tag "drug-maker" ;
  schema:addressCountry "CU" ;
  onco:drugs <https://onco.cc/drugs/nimotuzumab/> .